Lava’s EVP and Head of R&D, Paul Parren, PhD, and CSO, Hans van der Vliet, MD, PhD, will speak at the 12th Annual PEGS Europe Conference on Nov 11.

9am – Paul Parren – Next-Generation T Cell Engagers
9:20am – Hans van derVliet – Bispecific γδ-T Cell Engagers for Cancer Immunotherapy.
11:55am – Paul Parren – Panel Discussion: Gamma Delta T Cell Therapy